Olanzapine augmentation of fluvoxamine-refractory obsessive–compulsive disorder (OCD): a 12-week open trial
- 1 October 2000
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 96 (2) , 91-98
- https://doi.org/10.1016/s0165-1781(00)00203-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Olanzapine Addition in Obsessive-Compulsive Disorder Refractory to Selective Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 1999
- OlanzapineClinical Pharmacokinetics, 1999
- Focus on OlanzapineCurrent Medical Research and Opinion, 1999
- Response to Risperidone Addition in Fluvoxamine-Refractory Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry, 1996
- Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic ReviewThe British Journal of Psychiatry, 1995
- Biologic factors in schizotypal personal disordersActa Psychiatrica Scandinavica, 1994
- Exacerbation of Obsessive–Compulsive Symptoms Associated with ClozapineThe British Journal of Psychiatry, 1994
- A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1991
- Psychiatric Illness in First-Degree Relatives of Patients with Paranoid Psychosis, Schizophrenia and Medical IllnessThe British Journal of Psychiatry, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960